Results 151 to 160 of about 23,315 (198)

Peroxisome Proliferator-Activated Receptors (PPARs) in Psoriasis: Metabolic Intersections, Molecular Mechanisms, and Potential Treatments. [PDF]

Cureus
Pinnelli VBK, T SB, Ca J, Bhanu P, Murthuza AA, Thipani Madhu M, N S, Sam KT, Hussain MH, As A, Kandi V.   +10 more
europepmc   +1 more source

Nephroprotective and antioxidant properties of a novel herbal extract combination in a high-fat diet and alloxan-induced kidney injury in rats. [PDF]

J Adv Vet Anim Res
Yulizal OK, Darmadi D, Alchair OI, Putri ENZ, Zahiah WA, Simarmata TA.   +5 more
europepmc   +1 more source

Evidence-Based Management of MASLD: GRADE Evaluation of Pharmacological Therapies. [PDF]

Pharmaceuticals (Basel)
Karavia EA, Pittaras A, Andreopoulou O, Hatziri A, Makrydimitri A, Anagnostopoulos D, Vareltzis P, Kypreos KE.   +7 more
europepmc   +1 more source

Glucosylceramide regulates depression through activating peroxisome proliferator-activated receptor gamma in dorsal striatum. [PDF]

Theranostics
Jiang L, He Y, Liu H, Zhang D, Dai Y, Bu Q, Shi Q, Duan H, Zhao Y, Li S, Han S, Zhou Y, Zhao Y, Qin F, Chen Y, Wang L, Li H, Liu C, Qin M, Kuang W, Zhang N, Zhao Y, Cen X.   +22 more
europepmc   +1 more source

Cost effectiveness analysis of six non insulin agents for type 2 diabetes in Iran using a patient level simulation with UKPDS OM2. [PDF]

Sci Rep
Darvishi A, Daroudi R, Dehghan S, Heshmat R, Shafiee G.   +4 more
europepmc   +1 more source

Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes. [PDF]

Curr Diab Rep
Malandris K, Charalampidis K, Loomba R, Sinakos E.   +3 more
europepmc   +1 more source

Targeting the PPAR-γ/OPTN axis to inhibit apoptosis in steroid-induced glaucoma. [PDF]

iScience
Liang X, Li N, Gong Q, Wang H.
europepmc   +1 more source